Kuthala Kalyan Kumar, Meka Sowjanya, Kanikaram Sunita
Department of Zoology and Aquaculture, Acharya Nagarjuna University, Nagarjunanagar, Guntur, Andhra Pradesh 522 510, India.
Malar Res Treat. 2013;2013:426040. doi: 10.1155/2013/426040. Epub 2013 Jun 11.
To find out the efficacy and effect of artemisinin derivatives on haematological indices, C57BL/6J mice were challenged with Plasmodium falciparum and treated with therapeutic doses of AS, AE, and AL. Course of infection was studied in the infected and treated groups up to day 42. Peak level of parasitaemia (38%) was observed on day 11 in infected group. Haematological indices indicated significant (P < 0.05) decrease in RBC, WBC, haemoglobin, packed cell volume, mean cell volume, and platelet counts in infected mice. But all the parameters were restored to normal values, and significant (P < 0.05) changes were observed in all drug-treated groups. Insignificant changes were observed for MCHC (P > 0.05) in all drug-treated groups. Percent of peak parasitaemia was much reduced in AL- (3.2% on day 3) treated group in comparison with AE- (2.4% on day 4) and AS- (4% on day 2) treated groups. Parasites were completely cleared on day 6 in AS group, day 5 in AE group, and day 4 in AL group. Hence, our results strongly support that combination therapy has high efficacy rates than monotherapy. No adverse effects were observed on haematological parameters when animals were treated with therapeutic dosages.
为了探究青蒿素衍生物对血液学指标的疗效和影响,用恶性疟原虫感染C57BL/6J小鼠,并用治疗剂量的青蒿琥酯(AS)、蒿甲醚(AE)和青蒿素哌喹(AL)进行治疗。在感染和治疗组中研究感染过程直至第42天。感染组在第11天观察到最高疟原虫血症水平(38%)。血液学指标显示,感染小鼠的红细胞、白细胞、血红蛋白、血细胞比容、平均红细胞体积和血小板计数显著(P<0.05)降低。但所有参数均恢复到正常值,并且在所有药物治疗组中均观察到显著(P<0.05)变化。所有药物治疗组的平均红细胞血红蛋白浓度(MCHC)变化不显著(P>0.05)。与蒿甲醚治疗组(第4天为2.4%)和青蒿琥酯治疗组(第2天为4%)相比,青蒿素哌喹治疗组(第3天为3.2%)的最高疟原虫血症百分比大幅降低。青蒿琥酯组在第6天、蒿甲醚组在第5天、青蒿素哌喹组在第4天寄生虫被完全清除。因此,我们的结果有力地支持联合治疗比单一疗法具有更高的有效率。当用治疗剂量治疗动物时,未观察到对血液学参数的不良反应。